Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bactorinol Nasal Spray With Reduced-dose Mometasone in Chronic Rhinosinusitis
NCT07787494Not yet recruiting
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in chronic rhinosinusitis (CRS), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoint: Sino-Nasal Outcome Test-22 at 24 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT07787494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07787494.